
Jointly Sponsored by: Perelman School of Medicine at the University of Pennsylvania, The Penn Center for AIDS Research and ViralEd, Inc.
About the Program
Program Overview
The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to present this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is live webcast every Thursday at 12:00pm Eastern Time starting in October through June. All webcasts will be available for on-demand viewing immediately following the live broadcast. CME credit will be available for 24 hours following the start of each webcast.
Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.
Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hivgrandrounds for easy access.
Target Audience
This program has been designed for Family
Medicine, Pediatrics, Neurology, Psychiatry, Internal Medicine, Internal
Medicine - Infectious Disease
Commercial Support Acknowledgement
HIV Grand Rounds is supported by independent educational grants from Gilead Sciences, Inc., ViiV Healthcare, Janssen Therapeutics and Merck Sharp and Dohme Corp.
Learning Objectives
After completing this activity, participants should be better able to:
- Describe how to apply in clinical practice approaches for preventing HIV infection and getting newly diagnosed patients rapidly into care
- Discuss how to individualize ARV therapy for the treatment-naïve and treatment-experienced patients to support adherence and patient satisfaction
- Describe how to manage various patient populations, such as the aging patient with HIV infection, including issues associated with cardiovascular and bone disease, PWIDs and underserved populations
- Discuss the basic science concepts involved with HIV and be able to apply those concepts to HIV therapeutics and other issues involved in HIV patient care and HIV prevention
Course Directors
Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, Pennsylvania
Katherine Bar, MD
Assistant Professor
Department of Medicine
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, Pennsylvania
Florence Momplaisir, MD, MSHP, FACP
Assistant Professor of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
Next Session and Participation Information
Presented live at 12:00 PM ET, weekly on Thursdays and anytime On-Demand
- Delivered via webinar directly to you and/or your clinic
- You, or your clinic's coordinator, will receive a weekly email with topic, speaker and webinar link
- Sessions can be viewed in a large conference room or auditorium for large group viewing and participation, or directly on your personal computer, tablet or smart device
If CME credit is desired for any of the live sessions, proceed to https://upenn.cloud-cme.com to create your personal CME account. After your account is established this one time, following each session simply text the session code listed in the presentation slides to receive your CME credit.
Live Session Topics and Speakers
January 12, 2023
The Top Ten Publications in HIV Medicine in 2022
Ian Frank, MD
Click HERE to View On-Demand
January 19, 2023
Translocated microbiome composition determines immunological outcome in treated HIV infection
Daniel Douek, MD
Click HERE to View On-Demand
January 26, 2023
Rational Vaccine Strategies against HIV and Coronaviruses
Raiees Andrabi, PhD
Click HERE to View On-Demand
February 2, 2023
Understanding the HIV reservoir…one cell at a time
Michael R. Betts, PhD
Click HERE to View On-Demand
February 9, 2023
Differentiated service delivery for PrEP
Sara Clemens, MD
Click HERE to View On-Demand
March 2, 2023
Highlights from CROI 2023: Not the HIV Stuff
Ian Frank, MD
Click HERE to View On-Demand
March 9, 2023
Highlights from CROI 2023: The HIV Stuff
Paul Sax, MD
Click HERE to View On-Demand
March 16, 2023
Clinical Cases in HIV
Antonio Urbina, MD
Click HERE to View On-Demand
March 23, 2023
Of apps and equity: where do we stand in HIV prevention for MSM?
Patrick Sullivan, DVM, PhD, FACVPM
Click HERE to View On-Demand
March 30, 2023
History of Tuberculosis
Sneha Thatipelli, MD
Click HERE to View On-Demand
April 6, 2023
Findings from the Community PrEP Study: Leveraging community-based platforms to provide same-day PrEP initiation services and adherence support for adolescent girls and young women in South Africa
Andrew Marino-Medina, PhD
Click HERE to View On-Demand
April 13, 2023
COVID-19 among People with Immune Compromised Conditions: from Big Data to Clinical Epidemiology
Jing Sun, MD, MPH, PhD
Click HERE to View On-Demand
April 20, 2023
Seeing the unseen: Subclinical cardiomyopathy in newly diagnosed persons with HIV
Pieter-Paul S. Robbertse PhD, MBChB
Click HERE to View On-Demand
April 27, 2023
Fatty Liver in People with HIV
Jessie Torgersen, MD, MHS, MSCE
Click HERE to View On-Demand
May 4, 2023
Treatment of Drug-Resistant Pulmonary TB: Guidelines and Guidance
Gregory P. Bisson, MD, MSCE
Click HERE to View On-Demand
May 11, 2023
Considerations for the induction of protective B cell responses to HIV: Insights from animal models and high-risk populations
James Kobie, PhD
Click HERE to View On-Demand
May 18, 2023
HIV and COPD
Sarath Raju, MD, MPH
Click HERE to View On-Demand
May 25, 2023
Broadly neutralizing antibodies for HIV prevention and treatment
Katharine J. Bar, MD
Click HERE to View On-Demand
June 1, 2023
HIV Care in 2023 and Beyond
Jurgen Rockstroh, MD
Click HERE to View On-Demand
June 8, 2023
Weight gain with Antiretroviral Therapy: A Case-Based Approach
Todd Brown, MD, PhD
Click HERE to View On-Demand
June 15, 2023
Catalyzing Pediatric TB innovation (CAP TB): A Pre- and Post-Intervention Analysis
Jennifer Cohn, MD, MPH
Click HERE to View On-Demand
June 22, 2023
When Viruses Go Wild: How HIV and SARS-CoV-2 Can Become Unsuppressible
Jonathan Li, MD, MMSc
Click HERE to View On-Demand
September 7, 2023
Long Acting Small Molecule Plus bNAb Combinations for ART
Babafemi Taiwo, MBBS
Click HERE to View On-Demand
September 14, 2023
Highlights from the International AIDS Society Conference, Brisbane 2023
Renslow Sherer, MD
Click HERE toView On-Demand
September 28, 2023
Poverty Reduction to Improve HIV Outcomes — Mechanisms, Interventions, and Outcomes
Aaron Richterman, MD, MPH
Click HERE to View On-Demand
October 5, 2023
Immunotherapy and Progress Towards an HIV Cure
Steven G. Deeks, MD
Click HERE to View On-Demand
October 19, 2023
Life After HIV and Beyond
Adam Castillejo "The London Patient"
Click HERE to View On-Demand
October 26, 2023
Discovery Medicine for the Development of an HIV Neutralizing Vaccine
Troy Martin, MD, MPH
Click HERE to View On-Demand
November 2, 2023
Highlights from IDWeek 2023 and EACS 2023
Graeme Moyle, MD
Click HERE to View On-Demand
November 9, 2023
HCV Elimination: Can the US be free of HCV?
Stacey Trooskin, MD
Click HERE to View On-Demand
November 16, 2023
Novel treatments for HIV-associated cryptococcal meningitis: the AMBITION trial and beyond
Joe Jarvis, MSC, MBBMSC, MBBS, MRCP, PhD, DTMS
Click HERE to View On-Demand
November 30, 2023
Surviving a Plague: Aging with HIV
Heshie Zinman
Click HERE to View On-Demand
December 7, 2023
TBD
Hana El Sahly, MD
Click HERE to Register
December 14, 2023
Patient-Provider Communication and Potential Inequities in the Current Era of HIV Biomedical Prevention
Sarah Calabrese, PhD
Click HERE to Register
TO VIEW PREVIOUS HIV GRAND ROUNDS PLEASE SEE BELOW:
|
Hardware/Software Notice
You will need Internet to participate in this activity.
Accreditation
In support of improving patient care, Penn
Medicine is jointly accredited by the Accreditation Council for Continuing
Medical Education (ACCME), the Accreditation Council for Pharmacy Education
(ACPE), and the American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.
Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians
should claim only the credit commensurate with the extent of their
participation in the activity.
Nurses/Pharmacists:
This activity is not approved
for nursing or pharmacy contact hours
PAs: AAPA accepts certificates of participation for educational
activities certified for AMA PRA Category 1 Credit™ from organizations
accredited by ACCME or a recognized state medical society. PAs may receive a
maximum of 1.00 Category 1 credits for completing
this activity.
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at Penn Medicine Office of
Continuing Medical and Interprofessional Education for individuals who are in a
position to control the content of an educational activity to disclose to the
learners all relevant financial relationships that they have with any commercial
interest that provide products or services that may be relevant to the content
of this continuing education activity.
For this purpose, we consider relationships of the person involved to
include financial relationships of a spouse or partner.
The
intent of this policy is to ensure that Penn CME/CE certified activities
promote quality and safety, are effective in improving medical practice, are based
on valid content, and are independent of control from commercial interests and
free of commercial bias. Peer review of all content was conducted for all
faculty presentations whose disclosure information was found to contain
relationships that created a conflict of interest relevant to the topic of
their presentation. In addition, all faculty were instructed to provide
balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of Continuing Medical and Interprofessional Education (CME and
IPCE) have disclosed that they have no relevant financial
relationships with any commercial interests related to the content of
this
educational activity. Any peer reviewer with a potential conflict of
interest will recuse themselves from the peer review process.
The following faculty or planning committee members have
disclosed that they have no relevant financial relationships with any
commercial interests related to the content of this educational activity:
Florence Momplaisir, MD (Program Co-Director)
Planning Committee Members:
- ViralEd, Inc.: Brian Boyle, MD; Oliver Fultz; Rick Gordon
|
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:
Ian Frank, MD (Program Co-director)
- Advisor or Review Panel Member: Gilead; ViiV
- Consulting Fee: Johnson & Johnson; Moderna; Gilead (Relationship Ended); Merck (Relationship Ended)
- Grant/Research Support Recipient: Johnson & Johnson; Moderna; Pfizer; Sanofi Genzyme (Relationship Ended)
Katherin Bar, MD (Program Co-director)
- Consultant: Abbvie (Relationship Ended)
|
Discussion of Investigational and/or Off-label Use of Commercial Products and Devices
The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside DA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
|